雅虎香港 搜尋

搜尋結果

  1. 2023-24 季度接種季節性流感疫苗的人士中,本港錄得一宗吉-巴氏綜合症病例(於接種季節性流感疫苗後 五天至六周期間出現)。 2019 年至 2023 年期間,本港每年因 各種原因患上吉-巴氏綜合症而入住公立醫院的病例為33 至 60宗。

  2. 菲流達四價流感疫苗. VaxigripTetra. 衛部菌疫輸字 第 001036 號 須由醫師處方使用 版本日期 2024-08-29. 1性狀. 1.1有效成分及含量. 菲流達四價流感疫苗(含不活化的裂解病毒)每0.5毫升之劑量含有以下的流感病毒株*(不活化、裂解): A/Victoria/4897/2022 (H1N1)pdm09 - like strain (A/Victoria/4897/2022, IVR-238)......15 micrograms HA** A/Thailand/8/2022 (H3N2)-like strain (A/California/122/2022, SAN-022).....................15. micrograms HA**

  3. mein.sanofi.de › produkte › vaxigrip-tetraVaxigrip Tetra - Sanofi

    Produktinformationen. Beipackzettel (PDF) Fachinformation (PDF) FAQ – Häufig gestellte Fragen zu Vaxigrip Tetra finden Sie bei Sanofi Medical Information. Bitte beachten Sie, dass sich im Markt noch Packungen mit früheren Versionen der Packungsbeilage befinden können.

  4. 例如,Fluarix TM Tetra 含有 慶大霉素 (Gentamicin) 。 對雞蛋有輕度過敏的人士如欲接種流感疫苗,可於基層醫療接種滅活流感疫苗,而確診或懷疑對雞蛋有嚴重過敏反應的人士,應先由過敏學/免疫學專科醫生就雞蛋敏感進行評估,並因應臨牀需要,由過敏學/免疫 ...

  5. VAXIGRIP TETRA is indicated for the prevention of influenza disease caused by the two influenza. virus subtypes and the two influenza B virus types contained in the vaccine for: active immunisation of adults, including pregnant women, and children from 6 months of age. and older,

  6. 2024年8月31日 · Should I receive 2024-25 seasonal influenza vaccination? According to estimates from the United States (US) Centers for Disease Control and Prevention, influenza vaccines reduced the risk of influenza illness by 40% to 60% among the overall population during seasons when most circulating viruses closely matched with the vaccine strains.

  7. 2024年3月4日 · 疾管署表示,疫苗配送採先到貨、先鋪貨、先使用原則,民眾接種疫苗的廠牌採隨機安排,不過,若民眾偏好接種特定廠牌,可以事先打電話詢問疫苗廠牌,或至其他醫療院所施打。 不同廠牌流感疫苗保護力有差異嗎? 流感疫苗保護力因年齡或身體狀況不同而異,平均約可達30%至80%。

  8. The WHO recommends that trivalent vaccines for use in the 2023-2024 northern hemisphere influenza season contain the following: Egg-based vaccines an A/Victoria/4897/2022 (H1N1)pdm09-like virus; an A/Darwin/9/2021 (H3N2)-like virus; and a B/Austria/

  9. This vaccine complies with the WHO recommendations (Northern Hemisphere) for the 2023/2024. season. For the full list of excipients, see section 6.1. VaxigripTetra may contain traces of eggs, such as ovalbumin, and of neomycin, formaldehyde and octoxinol-9, which are used during the manufacturing process (see section 4.3). 3. PHARMACEUTICAL FORM.

  10. 2023年9月26日 · For the influenza season 2023/2024, there are nine tetravalent (containing four antigens of different influenza virus variants) influenza vaccine products that will be available for use in Germany having completed the approved seasonal strain update. This is the same amount of vaccines as were available in the previous season.